Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-13 Purchase |
2024-12-16 08:05 am |
Phathom Pharmaceuticals Inc. | PHAT | KARBE FRANK Director |
12,500 | $7.9267 | $99,084 | 57,000 (Direct) |
View |
| 2023-07-27 Purchase |
2023-07-31 07:58 am |
Better Therapeutics Inc. | BTTX | KARBE FRANK Chief Executive Officer |
137,005 | $0.7299 | $100,000 | 429,429 (Direct) |
View |
| 2023-04-10 Purchase |
2023-04-12 4:15 pm |
Better Therapeutics Inc. | BTTX | KARBE FRANK See Remarks |
242,424 | $0.825 | $200,000 | 292,424 (Direct) |
View |
| 2022-09-15 Purchase |
2022-09-15 8:53 pm |
Better Therapeutics Inc. | BTTX | KARBE FRANK See Remarks |
50,000 | $2.0939 | $104,695 | 50,000 (Direct) |
View |
| 2021-07-07 Sale |
2021-07-09 4:27 pm |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
3,232 | $21.75 | $70,296 | 212,296 (Direct) |
View |
| 2021-04-06 Sale |
2021-04-08 4:55 pm |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
11,080 | $18.63 | $206,420 | 152,390 (Direct) |
View |
| 2021-02-16 Sale |
2021-02-18 4:52 pm |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
750 | $21.4 | $16,050 | 345,214 (Direct) |
View |
| 2021-01-28 Sale |
2021-02-01 4:29 pm |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
300 | $24 | $7,200 | 345,964 (Direct) |
View |
| 2021-01-15 Sale |
2021-01-20 4:39 pm |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
750 | $21.5 | $16,125 | 346,264 (Direct) |
View |
| 2020-12-28 Sale |
2020-12-30 4:29 pm |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
11,800 | $30 | $354,000 | 347,014 (Direct) |
View |
| 2020-12-15 Sale |
2020-12-17 4:51 pm |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
1,050 | $24.15 | $25,363 | 358,814 (Direct) |
View |
| 2020-11-30 Sale |
2020-12-02 5:08 pm |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
1,500 | $24 | $36,000 | 359,864 (Direct) |
View |
| 2020-11-17 Sale |
2020-11-19 5:04 pm |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
750 | $20 | $15,000 | 361,364 (Direct) |
View |
| 2020-11-13 Sale |
2020-11-17 6:50 pm |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
750 | $20 | $15,000 | 362,114 (Direct) |
View |
| 2020-09-15 Sale |
2020-09-17 4:20 pm |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
750 | $21.73 | $16,298 | 362,864 (Direct) |
View |
| 2020-08-28 Sale |
2020-09-01 4:37 pm |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
24,800 | $20.02 | $496,421 | 584,908 (Direct) |
View |
| 2020-08-19 Sale |
2020-08-21 5:07 pm |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
700 | $20 | $14,000 | 388,414 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-24 Option Award |
2025-02-26 6:31 pm |
N/A 2035-02-23 |
Cidara Therapeutics Inc. | CDTX | KARBE FRANK Chief Financial Officer |
172,500 | $0 | 172,500 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-31 4:30 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | KARBE FRANK Director |
25,000 | $10.16 | 44,500 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-24 7:33 pm |
N/A 2034-05-22 |
Phathom Pharmaceuticals Inc. | PHAT | KARBE FRANK Director |
28,000 | $0 | 37,000 (Direct) |
View |
| 2023-12-18 Option Award |
2023-12-20 5:13 pm |
N/A N/A |
Better Therapeutics Inc. | BTTX | KARBE FRANK Chief Executive Officer |
62,500 | $0 | 526,516 (Direct) |
View |
| 2023-05-25 Option Award |
2023-05-30 6:48 pm |
N/A 2033-05-24 |
Phathom Pharmaceuticals Inc. | PHAT | KARBE FRANK Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2022-07-05 Option Award |
2022-07-07 4:32 pm |
N/A 2032-07-04 |
Better Therapeutics Inc. | BTTX | KARBE FRANK See Remarks |
472,200 | $0 | 472,200 (Direct) |
View |
| 2022-05-25 Option Award |
2022-05-27 4:41 pm |
N/A 2032-05-24 |
Phathom Pharmaceuticals Inc. | PHAT | KARBE FRANK Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-04-25 Option Award |
2022-04-26 5:21 pm |
N/A 2032-04-24 |
Phathom Pharmaceuticals Inc. | PHAT | KARBE FRANK Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-19 4:17 pm |
N/A 2031-04-14 |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
160,672 | $0 | 313,062 (Direct) |
View |
| 2021-02-16 Exercise |
2021-02-18 4:52 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
750 | $5.11 | 345,214 (Direct) |
View |
| 2021-02-16 Exercise |
2021-02-18 4:52 pm |
N/A 2026-09-20 |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
750 | $0 | 345,214 (Direct) |
View |
| 2021-01-28 Exercise |
2021-02-01 4:29 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
300 | $5.11 | 345,964 (Direct) |
View |
| 2021-01-28 Exercise |
2021-02-01 4:29 pm |
N/A 2026-09-20 |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
300 | $0 | 345,964 (Direct) |
View |
| 2021-01-15 Exercise |
2021-01-20 4:39 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
750 | $5.11 | 346,264 (Direct) |
View |
| 2021-01-15 Exercise |
2021-01-20 4:39 pm |
N/A 2026-09-20 |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
750 | $0 | 346,264 (Direct) |
View |
| 2020-12-28 Exercise |
2020-12-30 4:29 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
11,800 | $5.11 | 347,014 (Direct) |
View |
| 2020-12-28 Exercise |
2020-12-30 4:29 pm |
N/A 2026-09-20 |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
11,800 | $0 | 347,014 (Direct) |
View |
| 2020-12-15 Exercise |
2020-12-17 4:51 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
1,050 | $5.11 | 358,814 (Direct) |
View |
| 2020-12-15 Exercise |
2020-12-17 4:51 pm |
N/A 2026-09-20 |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
1,050 | $0 | 358,814 (Direct) |
View |
| 2020-11-30 Exercise |
2020-12-02 5:08 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
1,500 | $5.11 | 359,864 (Direct) |
View |
| 2020-11-30 Exercise |
2020-12-02 5:08 pm |
N/A 2026-09-20 |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
1,500 | $0 | 359,864 (Direct) |
View |
| 2020-11-17 Exercise |
2020-11-19 5:04 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
750 | $5.11 | 361,364 (Direct) |
View |
| 2020-11-17 Exercise |
2020-11-19 5:04 pm |
N/A 2026-09-20 |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
750 | $0 | 361,364 (Direct) |
View |
| 2020-11-13 Exercise |
2020-11-17 6:50 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
750 | $5.11 | 362,114 (Direct) |
View |
| 2020-11-13 Exercise |
2020-11-17 6:50 pm |
N/A 2026-09-20 |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
750 | $0 | 362,114 (Direct) |
View |
| 2020-09-15 Exercise |
2020-09-17 4:20 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
750 | $5.11 | 362,864 (Direct) |
View |
| 2020-09-15 Exercise |
2020-09-17 4:20 pm |
N/A 2026-09-20 |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
750 | $0 | 362,864 (Direct) |
View |
| 2020-08-28 Exercise |
2020-09-01 4:37 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
24,800 | $5.11 | 584,908 (Direct) |
View |
| 2020-08-28 Exercise |
2020-09-01 4:37 pm |
N/A 2026-09-20 |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
24,800 | $0 | 584,908 (Direct) |
View |
| 2020-08-19 Exercise |
2020-08-21 5:07 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
700 | $5.11 | 388,414 (Direct) |
View |
| 2020-08-19 Exercise |
2020-08-21 5:07 pm |
N/A 2026-09-20 |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
700 | $0 | 388,414 (Direct) |
View |
| 2020-05-05 Option Award |
2020-05-28 8:00 pm |
N/A 2030-05-04 |
ADURO BIOTECH INC. | ADRO | KARBE FRANK Director |
30,000 | $0 | 30,000 (Direct) |
View |